Web Analytics Made Easy - StatCounter
Megapixl
Search results

Illustration: Imatinib Cancer Drug Molecule. Tyrosine-Kinase Inhibitor. Skeletal Formula.

ID 187171324 © Molekuul | Megapixl.com

Imatinib cancer drug molecule. Tyrosine-kinase inhibitor. Skeletal formula

CATEGORIES

Not to be used in commercial
designs and/or advertisements.
Click here for terms and conditions.
Imatinib cancer drug molecule. Tyrosine-kinase inhibitor. Skeletal formula.

Royalty-Free

extended licenses

I-EL W-EL P-EL U-EL
Your image is downloading.

Sharing is not just caring, it's also about giving credit - add this image to your page and give credit to the talented photographer who captured it.:

© Molekuul | Megapixl.com
HTML code

KEYWORDS

imatinib cancer drug molecule tyrosinekinase inhibitor skeletal formula imatinibe tyrosine kinase philadelphia chromosome chronic myelogenous leukemia cml oncology bcrabl targeted gastrointestinal stromal tumor malignancy ckit pdgfr platelet derived growth factor receptor patent hydrogen carbon oxygen nitrogen atoms atomic molecular compound composition chemical chemistry structure line drawing flat icon vector

More images on Dreamstime

Nilotinib cancer drug molecule tyrosine kinase inhibitor. Skeletal formula.
Pazopanib cancer drug molecule tyrosine kinase inhibitor class. Skeletal formula.
Sorafenib cancer drug molecule. Tyrosine kinase inhibitor TKI.
Sorafenib cancer drug molecule. Tyrosine kinase inhibitor TKI.
Lapatinib cancer drug molecule. Dual tyrosine kinase inhibitor, used in treatment of breast cancer.
Lapatinib cancer drug molecule. Dual tyrosine kinase inhibitor, used in treatment of breast cancer.
Bosutinib chronic myelogenous leukemia CML drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase..
Pazopanib cancer drug molecule (tyrosine kinase inhibitor class). Atoms are represented as spheres with conventional color coding
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia CML and acute.
Bosutinib chronic myelogenous leukemia (CML) drug molecule. Tyrosine kinase inhibitor targeting Bcr-Abl and SRc family kinase
Ponatinib cancer drug molecule. Tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia (CML) and acute

Similar Images

Casual shoes, women\'s red pump shoes with wide heels made of genuine patent leather .
Casual shoes, women\'s red pump shoes with wide heels made of genuine patent leather .
Casual shoes, women\'s red pump shoes with wide heels made of genuine patent leather .
3D image of Imatinib skeletal formula
ADAMA Agricultural Solutions logo
Businessman working on tablet computer with patented icon on virtual screen
Casual shoes, women\'s red pump shoes with wide heels made of genuine patent leather .
Casual shoes, women\'s red pump shoes with wide heels made of genuine patent leather .
Original Stamp Concept
Imatinib
Person hand holding patented icon on virtual screen, Patent Copyright Law Business technology concept

More images by the same author

Thrombin structure
Alzheimer's disease amyloid beta peptide (1-42)
Human chorionic gonadotropin (HCG) molecule
Immunoglobulin G (IgG1, antibody) molecule
Insulin-like growth factor (IGF-1, somatomedin C)
Thyroxine hormone molecule, chemical structure.
The 22 standard amino acids - chemical structures
Unsaturated fatty acids (set)
Insulin molecule
Polypropylene (polypropene, PP) plastic, chemical structure - li
Tumor necrosis factor (TNF, cachexin, cachectin)
Nitric oxide (NO) free radical and signaling molecule.
View more